Equities

InventisBio Co Ltd

688382:SHH

InventisBio Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)7.50
  • Today's Change-0.17 / -2.22%
  • Shares traded3.77m
  • 1 Year change-44.65%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,9192,235724
Total Receivables, Net1833.984.25
Total Inventory------
Prepaid expenses202613
Other current assets, total------
Total current assets2,1232,265741
Property, plant & equipment, net314945
Goodwill, net------
Intangibles, net0.921.250.11
Long term investments------
Note receivable - long term3.24225.26
Other long term assets------
Total assets2,1622,348800
LIABILITIES
Accounts payable736264
Accrued expenses263321
Notes payable/short-term debt000
Current portion long-term debt/capital leases9.00128.71
Other current liabilities, total514.074.78
Total current liabilities15811199
Total long term debt2.611515
Total debt122724
Deferred income tax2.906.22--
Minority interest------
Other liabilities, total0.880.401.20
Total liabilities165133115
SHAREHOLDERS EQUITY
Common stock575575460
Additional paid-in capital3,7383,6711,773
Retained earnings (accumulated deficit)(2305)(2021)(1537)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(11)(10)(11)
Total equity1,9982,215685
Total liabilities & shareholders' equity2,1622,348800
Total common shares outstanding575575575
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.